会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Compositions and methods for enhancing phagocytosis or phagocyte activity
    • 用于增强吞噬作用或吞噬细胞活性的组合物和方法
    • US08198020B2
    • 2012-06-12
    • US10923940
    • 2004-08-23
    • Cedric FrancoisPascal DeschateletsPaul OlsonAlec Machiels
    • Cedric FrancoisPascal DeschateletsPaul OlsonAlec Machiels
    • C12Q1/70C12Q1/00G01N33/53G01N33/567G01N33/574
    • B82Y5/00A61K47/544A61K47/62A61K47/6911A61K47/6913
    • The present invention provides a system for enhancing clearance or destruction of undesirable cells or noncellular molecular entities by tagging such cells or noncellular molecular entities with a marker that targets the cells or noncellular molecular entities for phagocytosis (phagocytic marker). The target cells can be, for example, endothelial cells, tumor cells, leukocytes, or virus-infected cells. In certain embodiments of the invention the tagging is accomplished by administering a composition comprising an antibody or ligand linked to the phagcytotic marker, wherein the antibody or ligand binds to a cell type specific marker present on or in the cell surface of a target cell. In preferred embodiments of the invention, the phagocytic marker comprises phosphatidylserine or a group derived from phosphatidylserine, thrombospondin-1, annexin I, or a derivative of any of these.
    • 本发明提供了一种用于通过用靶向细胞或非细胞分子实体进行吞噬作用(吞噬标记)的标记来标记这样的细胞或非细胞分子实体来增强不需要的细胞或非细胞分子实体的清除或破坏的系统。 靶细胞可以是例如内皮细胞,肿瘤细胞,白细胞或病毒感染的细胞。 在本发明的某些实施方案中,标记通过施用包含与噬菌体标记物连接的抗体或配体的组合物来实现,其中所述抗体或配体结合存在于靶细胞的细胞表面上或细胞表面的细胞类型特异性标志物。 在本发明的优选实施方案中,吞噬标记物包含磷脂酰丝氨酸或衍生自磷脂酰丝氨酸,血小板反应素-1,膜联蛋白I或其任何衍生物的基团。
    • 2. 发明申请
    • Compositions and methods for enhancing phagocytosis or phagocyte activity
    • 用于增强吞噬作用或吞噬细胞活性的组合物和方法
    • US20050113297A1
    • 2005-05-26
    • US10923940
    • 2004-08-23
    • Cedric FrancoisPascal DeschateletsPaul OlsonAlec Machiels
    • Cedric FrancoisPascal DeschateletsPaul OlsonAlec Machiels
    • A61K38/17A61K47/48C12N5/08
    • B82Y5/00A61K47/544A61K47/62A61K47/6911A61K47/6913
    • The present invention provides a system for enhancing clearance or destruction of undesirable cells or noncellular molecular entities by tagging such cells or noncellular molecular entities with a marker that targets the cells or noncellular molecular entities for phagocytosis (phagocytic marker). The target cells can be, for example, endothelial cells, tumor cells, leukocytes, or virus-infected cells. In certain embodiments of the invention the tagging is accomplished by administering a composition comprising an antibody or ligand linked to the phagcytotic marker, wherein the antibody or ligand binds to a cell type specific marker present on or in the cell surface of a target cell. In preferred embodiments of the invention, the phagocytic marker comprises phosphatidylserine or a group derived from phosphatidylserine, thrombospondin-1, annexin I, or a derivative of any of these.
    • 本发明提供了一种用于通过用靶向细胞或非细胞分子实体进行吞噬作用(吞噬标记)的标记来标记这样的细胞或非细胞分子实体来增强不需要的细胞或非细胞分子实体的清除或破坏的系统。 靶细胞可以是例如内皮细胞,肿瘤细胞,白细胞或病毒感染的细胞。 在本发明的某些实施方案中,标记通过施用包含与噬菌体标记物连接的抗体或配体的组合物来实现,其中所述抗体或配体结合存在于靶细胞的细胞表面上或细胞表面的细胞类型特异性标志物。 在本发明的优选实施方案中,吞噬标记物包含磷脂酰丝氨酸或衍生自磷脂酰丝氨酸,血小板反应素-1,膜联蛋白I或其任何衍生物的基团。